THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Schonfeld Strategic Advisors LLC's Holding History (CIK: 0001665241)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 16,555 Value ($000) $310 Avg Close $16.59 Range $13.50 - $20.33

Q3 2023

Shares 57,426 Value ($000) $496 Avg Close $9.65 Range $8.25 - $10.59

Q2 2023

Shares 18,076 Value ($000) $187 Avg Close $11.04 Range $9.98 - $12.03

Q4 2022

Shares 29,160 Value ($000) $327 Avg Close $10.51 Range $9.56 - $11.83

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	16,555	$310	$16.59	$13.50 - $20.33
Q3 2023	57,426	$496	$9.65	$8.25 - $10.59
Q2 2023	18,076	$187	$11.04	$9.98 - $12.03
Q4 2022	29,160	$327	$10.51	$9.56 - $11.83